Germann UA, Alam JJ. P38α MAPK Signaling-A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease. Int J Mol Sci. 2020 Jul 31;21(15) PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Neflamapimod
  2. MW150

News

  1. In Phase 2 Trial, Neflamapimod Aids Cognition in Lewy Body Dementia

Research Models

  1. PA-Rab5